TINA'S WISH RESEARCHER DR. SAMUEL MOK RECOGNIZED IN TREATMENT BREAKTHROUGH

News

TINA’S WISH RESEARCHER DR. SAMUEL MOK RECOGNIZED IN TREATMENT BREAKTHROUGH

TINA’S WISH RESEARCHER DR. SAMUEL MOK RECOGNIZED IN TREATMENT BREAKTHROUGH

“Scientists have created a promising new way to treat late-stage ovarian and pancreatic cancers. The cancers are two of the most lethal and are known as ‘silent killers’ because they rarely trigger early symptoms and often go undetected until it is too late. Tests on mice showed a new kind of immunotherapy that targets the cells that grow around and support tumors. The drug will undergo further tests this year and, if successful, human trials will begin in 2020.”

CLICK HERE to read more.

Tina’s Wish Researcher Dr. Samuel C. Mok holds the Stephanie C. Stelter Professorship in the Department of Gynecologic Oncology & Reproductive Medicine at The University of Texas MD Anderson Cancer Center.  To learn more about Dr. Mok’s research, CLICK HERE.